438 related articles for article (PubMed ID: 27017124)
1. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma.
Zhang L; Wang N; Shen Q; Cheng W; Qian GJ
PLoS One; 2013; 8(10):e76119. PubMed ID: 24146824
[TBL] [Abstract][Full Text] [Related]
3. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation.
Vogl TJ; Farshid P; Naguib NN; Zangos S; Bodelle B; Paul J; Mbalisike EC; Beeres M; Nour-Eldin NE
Abdom Imaging; 2015 Aug; 40(6):1829-37. PubMed ID: 25601438
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
6. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
8. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
9. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
[TBL] [Abstract][Full Text] [Related]
10. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study.
Cillo U; Noaro G; Vitale A; Neri D; D'Amico F; Gringeri E; Farinati F; Vincenzi V; Vigo M; Zanus G;
HPB (Oxford); 2014 Nov; 16(11):979-86. PubMed ID: 24750429
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.
Brunello F; Cantamessa A; Gaia S; Carucci P; Rolle E; Castiglione A; Ciccone G; Rizzetto M
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):842-9. PubMed ID: 23442417
[TBL] [Abstract][Full Text] [Related]
14. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
[TBL] [Abstract][Full Text] [Related]
15. CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety.
Asvadi NH; Anvari A; Uppot RN; Thabet A; Zhu AX; Arellano RS
J Vasc Interv Radiol; 2016 Apr; 27(4):496-502; quiz 503. PubMed ID: 26922977
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
18. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.
Park MJ; Kim YS; Rhim H; Lim HK; Lee MW; Choi D
J Vasc Interv Radiol; 2011 Jun; 22(6):771-9. PubMed ID: 21616430
[TBL] [Abstract][Full Text] [Related]
19. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
